Last updated: 4 months ago
Citius Pharmaceuticals 8-K Report: Key Insights from February 14, 2025 Filing
Explore Citius Pharmaceuticals, Inc.'s 8-K report from February 14, 2025. Key insights include stock details, company info, and significant SEC disclosures essential for investors.